The quest for small-molecule cancer immunotherapeutics скачать в хорошем качестве

The quest for small-molecule cancer immunotherapeutics

What you will discover: how to design, validate and classify inhibitors for therapeutic applications You are: computational drug designers Speaker: Ute Röhrig Click to access specific sections of the talk: 02:10 Validation of inhibitors 06:01 Classification of inhibitors 09:07 Design of inhibitors 16:23 Summary and outlook Reference paper and resource Röhrig U et al. Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1). J. Med. Chem. 2021, 64, 24, 17690–17705 https://pubs.acs.org/doi/10.1021/acs.... Any question about this talk? Contact Ute Röhrig at Ute.Roehrig[at]sib.swiss. Visit the group's page: https://www.sib.swiss/olivier-michiel... More about the speaker: Ute F. Röhrig studied chemistry in Hamburg and Munich with a scholarship from the Studienstiftung des Deutschen Volkes. In 2004, she obtained a PhD degree from the Swiss Federal Institute of Technology Zurich (ETHZ) under the supervision of Ursula Röthlisberger. After a postdoctoral stay in Rome with Roberto Petronzio and Michele Parrinello, Ute F. Röhrig joined the Molecular Modeling Group at the SIB Swiss Institute of Bioinformatics in 2006, where she is presently working as a senior research scientist. She has also been privatdozent at the University of Lausanne since 2016. Her research interests include computational modeling and in silico drug design with experimental validation, especially using hybrid quantum and classical methods. Read the news on our website: https://www.sib.swiss/about-sib/news/... Register to the SIB "in silico talks" mailing list to receive a notification when the next talk is online: https://www.sib.swiss/training/in-sil... This video is available under the creative commons license CC BY 4.0 https://creativecommons.org/licenses/...